Blake graduated from Texas Christian University with a Bachelor of Science degree in Biology. Prior to graduate school, he held research positions at UT Southwestern, as a Research Technician in the Department of Pharmacology, and at Baylor College of Medicine / Texas Children's Hospital as a Postbaccalaureate Research Education Program (PREP) Student.
My research project is to examine how type I interferon signaling modulates the immunogenicity of head & neck (oral) cancer. I am interested in the understanding the mechanisms by which the type I interferon pathway is regulated, specifically focusing on the roles of NLR (nucleotide-binding domain and leucine rich repeat) proteins. I am additionally interested in understanding the molecular machinery cancer cells employ to develop resistance to immunogenic chemoradiotherapy.
Monte V. Hobbs Student Award (2020)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (F31-Diversity), National Institute of Dental and Craniofacial Research (NIDCR) (2019)
John H. Wallace Scholar, Autumn Immunology Conference, Chicago, IL (2018)
Honorable Mention, Excellence in Promoting Diversity, Equity, and Inclusion, Office of Graduate and Postdoctoral Studies, University of Michigan Medical School (2018)
Rackham Merit Fellowship, University of Michigan Rackham Graduate School (2015)
Benard Maas Fellowship, University of Michigan Rackham Graduate School (2015)
Donald Kerr Symposium, University of Michigan School of Dentistry, Ann Arbor, MI, June 13, 2019; Poster Title: Investigating the Dichotomous Role of STING-mediated Type I Interferons in Head and Neck Squamous Cell Carcinoma Progression
AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research, Austin, TX, April 29, 2019; Poster Title: Resolving STING-mediated tumor immune microenvironment shift at single-cell resolution
47th Annual Autumn Immunology Conference, Chicago, IL, November 18, 2018 Poster Title: NLRC3 Antagonizes STING-mediated Interferon Induction in Head and Neck Squamous Cell Carcinoma
Heath, Blake. "NLRC3 Antagonizes STING-mediated Interferon Induction in Head and Neck Squamous Cell Carcinoma." Rogel Cancer Center Spring Symposium, University of Michigan Medical School, Ann Arbor, MI. June 14, 2018.
University of Michigan School of Dentistry Research Day, Ann Arbor, MI, February 22, 2018; Poster Title: NLRC3 Antagonizes STING-mediated Interferon Induction in Head and Neck Squamous Cell Carcinoma